Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 5.16
-0.12 (-2.27%)
Aug 13, 2026, 5:29 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 139.18 million as of August 13, 2026. Its market cap has decreased by -33.52% in one year.
Market Cap
139.18M
Enterprise Value
85.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.16
ChartMarket Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has increased from 6.93M to 139.18M, an increase of 1,908.31%. That is a compound annual growth rate of 11.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 136.02M | 12.17% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 209.14M |
| Alzinova AB | 206.69M |
| Initiator Pharma | 177.29M |
| Abera Bioscience AB | 168.91M |
| Elicera Therapeutics AB | 166.51M |
| Biovica International AB | 160.55M |
| Diamyd Medical AB | 158.70M |
| Xintela AB | 156.32M |